Abo Bibliothek: Guest
Critical Reviews™ in Oncogenesis

Erscheint 4 Ausgaben pro Jahr

ISSN Druckformat: 0893-9675

ISSN Online: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

YY1 Is an Inducer of Cancer Metastasis

Volumen 22, Ausgabe 1-2, 2017, pp. 1-11
DOI: 10.1615/CritRevOncog.2017021314
Get accessGet access

ABSTRAKT

Yin Yang 1 (YY1) is a member of the GLI–Kruppel family of zinc finger proteins that plays vital roles in many biological processes, especially tumorigenesis. To date, ample evidence suggests a critical regulatory role of YY1 in tumor cell metastasis. The potential of YY1 as a valuable biomarker for cancer metastasis has been increasingly known. Here, we review the studies related to the expression, regulatory network, and clinical application of YY1 in cancer metastasis. We first summarize YY1 expression patterns in metastatic tumors. We then elaborate YY1-regulated mechanisms on five aspects, including epithelial–mesenchymal transition, cell migration and invasion, stemness, polyploidy, and genomic stability. Finally, we discuss the correlation between YY1 expression and clinical outcomes and therapeutic potential of YY1 in cancer treatment. Based on this review, we conclude that YY1 is a bona fide inducer of cancer metastasis and can serve as a clinical biomarker and therapeutic target for cancer treatment.

REFERENZIERT VON
  1. Hays Emily, Bonavida Benjamin, YY1 regulates cancer cell immune resistance by modulating PD-L1 expression, Drug Resistance Updates, 43, 2019. Crossref

  2. You Qi, Yao Yuan, Wu Jinyu, Cheng Congcong, Li Yunxiu, Yuan Haitao, RETRACTED: YY1-induced lncRNA DSCR8 promotes the progression of ovarian cancer via miR-3192-5p/YY1 axis, Biomedicine & Pharmacotherapy, 129, 2020. Crossref

  3. Li Dangdang, Stovall Daniel B., Wang Wenmeng, Sui Guangchao, Advances of Zinc Signaling Studies in Prostate Cancer, International Journal of Molecular Sciences, 21, 2, 2020. Crossref

  4. Özenver Nadire, Efferth Thomas, Therapeutic targeting of SNAIL, RKIP, and YY1 in tumor metastasis and drug resistance, in Prognostic and Therapeutic Applications of RKIP in Cancer, 2020. Crossref

  5. Qian Sumin, Wang Wei, Li Meng, Transcriptional factor Yin Yang 1 facilitates the stemness of ovarian cancer via suppressing miR-99a activity through enhancing its deacetylation level, Biomedicine & Pharmacotherapy, 126, 2020. Crossref

  6. D'Este Francesca, Della Pietra Emilia, Badillo Pazmay Gretta Veronica, Xodo Luigi E., Rapozzi Valentina, Role of nitric oxide in the response to photooxidative stress in prostate cancer cells, Biochemical Pharmacology, 182, 2020. Crossref

  7. Bhaskar Rao Divya, Panneerpandian Ponmathi, Balakrishnan Karthik, Ganesan Kumaresan, YY1 regulated transcription‐based stratification of gastric tumors and identification of potential therapeutic candidates, Journal of Cell Communication and Signaling, 15, 2, 2021. Crossref

  8. Wang Yuhao, Bonavida Benjamin, The role of YY1 in the pathogenesis of rheumatoid arthritis: A tale of cytokines, ncRNAs, and aberrant fibroblast-like synoviocytes (FLSs), in YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer, 2021. Crossref

  9. Martinez-Ruiz Gustavo Ulises, Morales-Sanchez Abigail, YY1 regulation of the cancer stem cell phenotype, in YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer, 2021. Crossref

  10. Gao Qianfu, Wang Shanchao, Zhang Zeyan, E3 ubiquitin ligase SMURF2 prevents colorectal cancer by reducing the stability of the YY1 protein and inhibiting the SENP1/c-myc axis, Gene Therapy, 2021. Crossref

  11. Qiao Shiyao, Wang Wenmeng, Yi Cheng, Xu Qingqing, Wang Wenfei, Shi Jinming, Stovall Daniel B., Li Dangdang, Sui Guangchao, YY1 Oligomerization Is Regulated by Its OPB Domain and Competes with Its Regulation of Oncoproteins, Cancers, 14, 7, 2022. Crossref

  12. Zhang Yang, Hyle Judith, Wright Shaela, Shao Ying, Zhao Xujie, Zhang Hui, Li Chunliang, A cis -element within the ARF locus mediates repression of p16 INK4A expression via long-range chromatin interactions , Proceedings of the National Academy of Sciences, 116, 52, 2019. Crossref

  13. Kwiatkowska Dominika, Mazur Ewelina, Reich Adam, YY1 Is a Key Player in Melanoma Immunotherapy/Targeted Treatment Resistance, Frontiers in Oncology, 12, 2022. Crossref

  14. Yang Xi, Wang Leiming, Zhou Fei, Ye Song, Sun Qianghu, Yin Yang 1-induced activation of LINC01133 facilitates the progression of pancreatic cancer by sponging miR-199b-5p to upregulate myelin regulatory factor expression, Bioengineered, 13, 5, 2022. Crossref

  15. Han Seong-Su, Wen Kuo-Kuang, Vyas Yatin M., Deficiency of Wiskott–Aldrich syndrome protein has opposing effect on the pro-oncogenic pathway activation in nonmalignant versus malignant lymphocytes, Oncogene, 40, 2, 2021. Crossref

Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen Preise und Aborichtlinien Begell House Kontakt Language English 中文 Русский Português German French Spain